This is unpublished

Scott
Tykodi
M.D.
Ph.D.

he, him, his
Physician & Research Faculty
Pinned
Academic
Associate Professor, Division of Medical Oncology, University of Washington
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Sites of Practice
Seattle Cancer Care Alliance

Photo: SCCA

Education, Training, Board Certifications 

  • M.D., Washington University School of Medicine 
  • Residency, Barnes Jewish Hospital, Washington University School of Medicine 
  • Oncology Fellowship, UW/Fred Hutch 
  • Ph.D., Washington University School of Medicine
  • Medical Oncology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine 

Clinical Expertise

  • Melanoma and Kidney Cancer

Affiliations 

Publications

Research and/or clinical interests

Dr. Scott Tykodi specializes in translating immunotherapy advances from the laboratory into the clinic. He has led numerous clinical trials evaluating novel, immune-based therapeutics for patients with kidney cancer or other solid tumors. Dr. Tykodi is developing a new cellular immunotherapy for kidney cancer aimed at a marker called 5T4, which is found on the surface of almost all kidney cancer cells and only rarely on healthy adult cells.